First world conference on luteinizing hormone in ART: Landing in Latin America

Reproductive medicine

Fertility

Regional workshop by Excemed

Friday, Apr 7 - Saturday, Apr 8 2017

Mexico City, Mexico

Accreditation

EACCME®

Language

The official language of this live educational conference will be English.

Simultaneous translation will be provided from English to Spanish and vice versa.

Registration status

Closed

To register for this event, contact

For registration and accommodation please contact:
Meridiano Congress International
Project Manager: Giorgia Di Egidio
T +39 06 88 595 245 F +39 06 88 595 234
giorgia.diegidio@meridiano.it

Registration fee

150.00€

The registration fee is 150€ and includes:
• Access to scientific sessions
• Educational materials
• Certificate of attendance
• Coffee breaks and luncheons

Target audiences

Clinicians

embryologists

biologists and scientists working in ART.

Files

Final Programme

Introduction

Access resources by clicking the Outcomes tab or scroll down to the Scientific Programme.

EXCEMED designed this programme in partnership with Omnia Education

Overview

This conference will review and further enlighten the main topics discussed during the First world conference on luteinizing hormone (LH) in ART: A flight of discovery in Naples, Italy on 27-28 May 2016. The role of LH during folliculogenesis has heightened curiosity for at least three decades. In particular, the scientific community is still divided over recognizing the relevance of LH containing drugs during controlled ovarian stimulation (COS). Availability of recombinant drugs has offered, for the first time, the opportunity to explore the role of the follicle stimulating hormone (FSH) and LH separately. Despite this opportunity, the role of recombinant LH is still a matter of debate. This conference will show evidence from basic science to clinical practice regarding the use of recombinant LH and will illustrate its possible benefits as well as its physiopathological mechanism. Guided by experts, participants will grasp the rationale for using recombinant LH in assisted reproductive technology as well as understand the role of LH in human reproduction.

Learning objectives

• Understand the physiology of LH and its role in ovulation induction
• Grasp the state of the art regarding the use of recombinant LH
• Individualise groups of patients that required LH during stimulation protocols
• Identify specific ovarian reserve markers and genotype polymorphisms useful for tailoring treatments and choosing the best approach

Accreditation details

EXCEMED (www.excemed.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ® ) to provide the following CME activity for medical specialists. The EACCME ® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net

The CME conference “First world conference on luteinizing hormone in ART: Landing in Latin America” held on 7-8 April 2017 in Mexico City, Mexico is designated for a maximum of 6 (six) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized by the American Medical Association (AMA) towards the Physician’s Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.